Table 3:

Multivariable adjusted hazard ratios for time to death

Medication/category	Median time until death (Q1, Q3), min*	HR (95% CI)
Lidocaine (Ref = none)	8 (6, 10)
Low-dose	6 (7, 12)	0.8 (0.6–1.0)
Standard-dose	9 (6, 12)	0.6 (0.6–0.7)
High-dose	8 (6, 10)	0.8 (0.7–0.9)
Propofol (Ref = low-dose)	8 (5, 11)
None	7 (6, 15)	1.4 (0.5–1.0)
Standard-dose	9 (6, 12)	0.9 (0.8–1.0)
High-dose	12 (8, 16)	0.4 (0.3–0.5)
Paralytic (Ref = standard-dose rocuronium)	9 (6, 12)
Rocuronium
Low-dose	9 (6, 11)	0.9 (0.8–1.0)
High-dose	14 (8, 22)	0.4 (0.3–0.7)
Cisatracurium
Standard-dose	9 (12, 13)	1.0 (0.9–1.0)
Low-dose	14†	0.8 (0.1–5.6)
High-dose	17 (14, 43)	0.4 (0.1–1.3)
Bupivacaine (Ref = none)	9 (6, 12)
Low-dose	8 (5, 12)	1.0 (0.8–1.3)
Standard-dose	8 (5, 12)	1.2 (1.0–1.3)
High-dose	8 (6, 20)	0.7 (0.4–1.2)
Potassium chloride (Ref = none)	9 (6, 12)
Low-dose	10 (8, 13)	1.3 (0.5–3.5)
Standard-dose	7 (5, 9)	1.2 (0.9–1.4)
High-dose	14 (11, 15)	0.7 (0.3–1.6)

Note: CI = confidence interval, HR = hazard ratio, Ref = reference category.

^*Unadjusted for covariates.

^†One patient.